Predictors of quality of life among adults with self-reported cancer related cognitive impairment

References

• Lv L, Mao S, Dong H, et al. Pathogenesis, assessments, and management of Chemotherapy-Related Cognitive Impairment (CRCI): an updated literature review. J Oncol. 2020;2020:3942439.
   PubMed Web of Science ®Google Scholar
• Torrente NC, Pastor J-BN, de la Osa Chaparro N. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy. J Cancer Survivorship. 2020;14(4):464-482.
   Web of Science ®Google Scholar
• Padgett LS, Van Dyk K, Kelly NC, et al. Addressing cancer-related cognitive impairment in cancer survivorship. Oncol Issues. 2020;35(1):52–57.
   Google Scholar
• Hardy SJ, Krull KR, Wefel JS, et al. Cognitive changes in cancer survivors. Am Soc Clin Oncol Educ Book. 2018;38:795–806.
   PubMedGoogle Scholar
• Olson B, Marks DL. Pretreatment cancer-related cognitive impairment—mechanisms and outlook. Cancers. 2019;11(5):687.
   PubMed Web of Science ®Google Scholar
• Trachtenberg E, Mashiach T, Ben Hayun R, et al. Cognitive impairment in Hodgkin lymphoma survivors. Br J Haematol. 2018;182(5):670–678.
   PubMed Web of Science ®Google Scholar
• Lange M, Joly F, Vardy J, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925–1940.
   PubMed Web of Science ®Google Scholar
• De Rosa N, Della Corte L, Giannattasio A, et al. Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study. Arch Gynecol Obstet. 2021;303(6):1581–1588.
   Google Scholar
• Von Ah D, Russell KM, Storniolo AM, et al. editors. Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum. 2009;36(3):326–226.
   Google Scholar
• Lycke M, Lefebvre T, Pottel L, et al. Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients. J Psychosoc Oncol. 2019;37(4):427–440.
   PubMed Web of Science ®Google Scholar
• Henneghan AM, Van Dyk K, Kaufmann T, et al. Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. JNCI J Natl Cancer Institute. 2021;113(12):1625–1633.
   PubMedGoogle Scholar
• Hutchinson AD, Hosking JR, Kichenadasse G, et al. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–934.
   PubMed Web of Science ®Google Scholar
• Hsu Y-H, Chen VC-H, Hsieh C-C, et al. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms. Breast Cancer. 2021;28(1):236–245.
   PubMed Web of Science ®Google Scholar
• Jean CY, Syrjala KL. Anxiety and depression in cancer survivors. Med Clin North Am. 2017;101(6):1099–1113.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Vardy J, Ahles T, et al. International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703–708.
   PubMed Web of Science ®Google Scholar
• Almutairi K, Mansour E, Vinluan J. A cross-sectional assessment of quality of life of breast cancer patients in Saudi Arabia. Public Health. 2016;136:117–125.
   PubMed Web of Science ®Google Scholar
• WHOQOL. The world health organization quality of life assessment (WHOQOL): position paper from the world health organization. Soc Sci Med. 1995;41(10):1403–1409.
   PubMed Web of Science ®Google Scholar
• Büttner M, Zebralla V, Dietz A, et al. Quality of life measurements: any value for clinical practice? Curr Treat Options Oncol. 2017;18(5):30.
   PubMed Web of Science ®Google Scholar
• Van Leeuwen M, Husson O, Alberti P, et al. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes. 2018;16(1):1–15.
   PubMedGoogle Scholar
• El Haidari R, Abbas LA, Nerich V, et al. Factors associated with health-related quality of life in women with breast cancer in the middle east: a systematic review. Cancers. 2020;12(3):696.
   PubMed Web of Science ®Google Scholar
• Shen A, Qiang W, Wang Y, et al. Quality of life among breast cancer survivors with triple negative breast cancer–role of hope, self-efficacy and social support. Eur J Oncol Nurs. 2020;46:101771.
   PubMed Web of Science ®Google Scholar
• Sleight AG, Lyons KD, Vigen C, et al. The association of health-related quality of life with unmet supportive care needs and sociodemographic factors in low-income Latina breast cancer survivors: a single-centre pilot study. Disabil Rehabil. 2019;41(26):3151–3156.
   PubMed Web of Science ®Google Scholar
• Rabin EG, Heldt E, Hirakata VN, et al. Quality of life predictors in breast cancer women. Eur J Oncol Nurs. 2008;12(1):53–57.
   PubMed Web of Science ®Google Scholar
• Levine EG, Yoo GJ, Aviv C. Predictors of quality of life among ethnically diverse breast cancer survivors. Applied Res Quality Life. 2017;12(1):1–16.
   PubMed Web of Science ®Google Scholar
• Park J-H, Jung YS, Jung Y-M, et al. The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients. Support Care Cancer. 2019;27(7):2707–2714.
   PubMed Web of Science ®Google Scholar
• Wells M, Swartzman S, Lang H, et al. Predictors of quality of life in head and neck cancer survivors up to 5 years after end of treatment: a cross-sectional survey. Support Care Cancer. 2016;24(6):2463–2472.
   PubMed Web of Science ®Google Scholar
• Foster C, Fenlon D. Recovery and self-management support following primary cancer treatment. Br J Cancer. 2011;105(S1):S21–S28.
   PubMed Web of Science ®Google Scholar
• Bandura A. Self‐efficacy. Corsini Encyclopedia Psychol. 2010;(10):1–3.
   Google Scholar
• Chirico A, Lucidi F, Merluzzi T, et al. A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life. Oncotarget. 2017;8(22):36800–36811.
   PubMedGoogle Scholar
• Hinz A, Friedrich M, Kuhnt S, et al. The influence of self-efficacy and resilient coping on cancer patients' quality of life. Eur J Cancer Care. 2019;28(1):e12952.
   PubMed Web of Science ®Google Scholar
• Wagland R, Fenlon D, Tarrant R, et al. Rebuilding self-confidence after cancer: a feasibility study of life-coaching. Support Care Cancer. 2015;23(3):651–659.
   PubMed Web of Science ®Google Scholar
• De Castro EK, Ponciano C, Meneghetti B, et al. Quality of life, self-efficacy and psychological well-being in brazilian adults with cancer: a longitudinal study. PSYCH. 2012;03(04):304–309.
   Google Scholar
• Wheelwright S, Permyakova NV, Calman L, et al. Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the colorectal wellbeing (crew) study. PLOS One. 2020;15(4):e0231332.
   PubMed Web of Science ®Google Scholar
• McVay JC, Kane MJ. Conducting the train of thought: working memory capacity, goal neglect, and mind wandering in an executive-control task. J Exp Psychol Learn Memory Cognition. 2009;35(1):196.
   PubMed Web of Science ®Google Scholar
• Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579.
   PubMed Web of Science ®Google Scholar
• Lindqvist Bagge A-S, Carlander A, Fahlke C, et al. Health-related quality of life (FACT-GP) in Sweden. Health Qual Life Outcomes. 2020;18(1):1–10.
   PubMedGoogle Scholar
• Pidala J, Kurland BF, Chai X, et al. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the chronic graft-versus-Host disease consortium. Haematologica. 2011;96(10):1528–1535.
   PubMed Web of Science ®Google Scholar
• Pylyshyn ZW, Storm RW. Tracking multiple independent targets: evidence for a parallel tracking mechanism. Spat Vis. 1988;3(3):179–197.
   PubMedGoogle Scholar
• Rosenberg M, Noonan S, DeGutis J, et al. Sustaining visual attention in the face of distraction: a novel gradual-onset continuous performance task. Atten Percept Psychophys. 2013;75(3):426–439.
   PubMed Web of Science ®Google Scholar
• Wagner LI, Sweet J, Butt Z, et al. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7(6):W32–W39.
   Google Scholar
• Dyk KV, Crespi CM, Petersen L, et al. Identifying cancer-related cognitive impairment using the FACT-Cog perceived cognitive impairment. JNCI Cancer Spectr. 2020;4(1):pkz099.
   PubMed Web of Science ®Google Scholar
• Lai JS, Wagner LI, Jacobsen PB, et al. Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology. 2014;23(10):1133–1141.
   PubMed Web of Science ®Google Scholar
• Von Ah D, Tallman EF. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manage. 2015;49(4):697–706.
   PubMed Web of Science ®Google Scholar
• Chen G, Gully SM, Eden D. Validation of a new general self-efficacy scale. Organizational Res Methods. 2001;4(1):62–83.
   Web of Science ®Google Scholar
• Wood R, Bandura A. Impact of conceptions of ability on self-regulatory mechanisms and complex decision making. J Pers Soc Psychol. 1989;56(3):407–415.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Kesler SR, Noll KR, et al. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–138.
   PubMed Web of Science ®Google Scholar
• Morse R, Rodgers J, Verrill M, et al. Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. Eur J Cancer. 2003;39(16):2288–2297.
   PubMed Web of Science ®Google Scholar
• Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3(4):223–232.
   PubMed Web of Science ®Google Scholar
• Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014. p. 19–30.
   Google Scholar
• Von Ah D, Crouch A. Cognitive rehabilitation for cognitive dysfunction after cancer and cancer treatment: implications for nursing practice. Semin Oncol Nurs. 2020;36(1):150977.
   PubMed Web of Science ®Google Scholar